Advertisement
A demo

Merck shares jump after combination trial shows Keytruda extends lung cancer survival

Jan 17, 2018 , CNBC Health
Merck's blockbuster drug Keytruda in combination with two chemotherapy drugs was successful as a first line treatment for lung cancer.

Read the full story...


Trending healthcare news keywords at this moment

walgreens big medicare patients care cancer case tied risk doctors surgery ebola outbreak african swine fever media breast kids experts drug hurricane michael safety tip lower pain study diabetes medicaid flu state highlights cases children disease zika healthcare costs digital ceo hospital states medical treatment heart patient supplements research cvs pharma fda drugs china reports rates data watch rise prices report products launches older ads polio-like opioid brain